
|Articles|August 1, 2001
The American Journal of Managed Care
- August 2001
- Volume 7
- Issue 8
Prevalence, Costs, and Treatment of Alzheimer's Disease and Related Dementia: A Managed Care Perspective
Advertisement
Articles in this issue
about 24 years ago
Hospice Use in Medicare Managed Care and Fee-for-Service Systemsabout 24 years ago
Healthcare Ethics Committees and Managed Careabout 24 years ago
Managed Care Can Make a Difference: The Need for Care at the End of LifeNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
4
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
5















































